- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02193178
Multicenter Dispensing Study of Biofinity Toric Made-To-Order Lenses in Extended Power Ranges
July 19, 2020 updated by: CooperVision, Inc.
The study hypothesis is that the Biofinity Toric XR lenses will perform as well as or better than the participants' habitual contact lenses.
Study Overview
Detailed Description
The study hypothesis is that the Biofinity Toric XR lenses will perform as well as or better than the participants' habitual contact lenses.
Further, that a minimum of 80% of those enrolled will complete 2 weeks of lens wear with no contraindication to continue.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Bloomington, Indiana, United States, 47405
- Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University
-
-
Texas
-
Houston, Texas, United States, 77204
- Texas Eye Research and Technology Center (TERTC) College of Optometry, University of Houston
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Has had an oculo-visual examination in the last two years
- Is at least 18 years of age and has full legal capacity to volunteer
- Has read and understood the information consent letter
- Is willing and able to follow instructions and maintain the appointment schedule
- Is correctable to a visual acuity of 20/50 or better (in at least one eye)
- Currently wears soft toric contact lenses in both eyes
Subject contact lens prescription must fall under one of the contact lens power ranges for at least one eye:
- -20.00D to -10.50D spherical powers and cylinder powers from - 0.75 to -2.25
- +8.50D to +20.00D spherical powers and cylinder powers from - 0.75 to -2.25
- -20.00D to -6.50D spherical powers and cylinder powers from -2.75 to -5.75
- -6.00D to +6.00D spherical powers and cylinder powers from -2.75 to -5.75
- +6.50D to +20.00D spherical powers and cylinder powers from-2.75 to -5.75
- Has clear corneas and no active ocular disease
- Demonstrates an acceptable fit with the study lenses
Exclusion Criteria:
- Has never worn contact lenses before;
- Has any systemic disease affecting ocular health;
- Is using any systemic or topical medications that will affect ocular health;
- Has any ocular pathology or abnormality that would affect the wearing of contact lenses;
- Has undergone corneal refractive surgery;
- Is participating in any other type of eye related clinical or research study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: comfilcon A toric
Participants are habitual toric lens wearers and will be fitted with comfilcon A toric lenses.
|
Contact lenses
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Comfort
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
Subjective ratings for overall comfort for habitual lenses assessed 2 weeks prior to baseline and for comfilcon A lenses assessed at baseline and 2 weeks post baseline.
Scale 0-100, 0=cannot be worn, causes pain, and 100=cannot be felt ever.
|
2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
|
Overall Vision
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post
|
Subjective ratings for overall vision for habitual lenses assessed 2 weeks prior to baseline and vision for comfilcon A assessed at baseline and 2 weeks post.Scale 0-100, 0=Extremely poor vision all of the time, cannot function, 100=Excellent vision all of the time.
|
2 weeks prior to baseline, Baseline, 2 weeks post
|
|
Handling
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
Subjective ratings for handling for habitual lenses assessed 2 weeks prior to baseline and handling for comfilcon A assessed at baseline and 2 weeks post baseline.
Scale 0-100, 0=Very difficult, 100=Very easy
|
2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
|
Overall Satisfaction
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
Subjective ratings for overall satisfaction for habitual lenses assessed 2 weeks prior to baseline and overall satisfaction for comfilcon A assessed at baseline and 2 weeks post baseline.
Scale 0-100, 0=Extremely dissatisfied, 100=Extremely satisfied.
|
2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
|
Lens Fit - Rotation
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
Lens Fit (rotation) for habitual lenses were assessed 2 weeks prior to baseline and then refitted with comfilcon A lenses.
After refitting with comfilcon A, lens fit rotation was assessed at baseline and 2 weeks.
Lens rotation was measured within 10 degrees of the desired 6 o'clock position.
Scale 0-180 degrees, 0=no rotation, 180=max rotation.
|
2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
|
Lens Fit - Overall Stability
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
Lens Fit (stability) for habitual lenses assessed 2 weeks prior to baseline and then refitted with comfilcon A lenses.
After refitting with comfilcon A lenses, stability was assessed at baseline and 2 weeks.
Scale 0-4, 0=Totally unstable, can't be worn to provide acceptable vision correction for an astigmatism, 4=Excellent orientation and optimum rotational recovery and stability
|
2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
|
Lens Fit Acceptance
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
General lens fit acceptance for habitual lenses assessed 2 weeks prior to baseline and refitted with comfilcon A lenses, which were assessed at baseline and at 2 weeks.
(Scale 0-4, 0=Can't be worn; 4=Optimum)
|
2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
|
Anterior Ocular Health - Palpebral Hyperemia and Roughness
Time Frame: Baseline and 2 weeks
|
Palpebral hyperemia and roughness for comfilcon A lenses assessed at baseline and 2 weeks.
Scale 0-4, 0=None, 4=Severe
|
Baseline and 2 weeks
|
|
Anterior Ocular Health - Bulbar and Limbal Redness
Time Frame: Baseline and 2 weeks
|
Bulbar and limbal redness for comfilcon A lenses assessed at baseline and 2 weeks.
Scale 0-4, 0=None; 4=Severe injection
|
Baseline and 2 weeks
|
|
Anterior Ocular Health - Corneal Staining
Time Frame: Baseline and 2 weeks
|
Corneal staining for comfilcon A lenses assessed at baseline and 2 weeks.
Scale 0-4, 0=No staining; 4= >45% of area
|
Baseline and 2 weeks
|
|
Anterior Ocular Health - Conjunctival Staining and Indentation
Time Frame: Baseline and 2 weeks
|
Conjunctival staining and indentation for comfilcon A lenses assessed at baseline and 2 weeks.
Conjuctival staining scale 0-4, 0=None, 4=Severe
|
Baseline and 2 weeks
|
|
Visual Acuity
Time Frame: 2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
Visual acuity for habitual lenses assessed 2 weeks prior to baseline and for comfilcon A assessed at baseline and 2 weeks post baseline using logMAR.
|
2 weeks prior to baseline, Baseline, 2 weeks post baseline
|
|
Subjective Preference - Comfort
Time Frame: Baseline and 2 weeks
|
Subjective preference for comfort between habitual lenses and comfilcon A lenses assessed at baseline and 2 weeks.
Preference choices: Prefers comfilcon A lenses, No preference, Prefers habitual lenses
|
Baseline and 2 weeks
|
|
Preference - Vision
Time Frame: Baseline and 2 weeks
|
Subjective preference for vision between habitual lenses and comfilcon A lenses assessed at baseline and 2 weeks.
Preference choices: Prefers comfilcon A lenses, No preference, Prefers habitual lenses
|
Baseline and 2 weeks
|
|
Preference - Handling
Time Frame: Baseline and 2 weeks
|
Subjective preference for handling between habitual lenses and comfilcon A lenses assessed at baseline and 2 weeks.
Preference choices: Prefers comfilcon A lenses, No preference, Prefers habitual lenses
|
Baseline and 2 weeks
|
|
Overall Preference
Time Frame: Baseline and 2 weeks
|
Overall subjective preference between habitual lenses and comfilcon A lenses assessed at baseline and 2 weeks.
Preference choices: Prefers comfilcon A lenses, No preference, Prefers habitual lenses
|
Baseline and 2 weeks
|
|
Investigator Acceptability
Time Frame: Baseline and 2 weeks
|
Investigator's preference on acceptability of refitting subjects in to comfilcon A lens based on lens performance assessed at baseline and 2 weeks.Scale 1-5, 1=Strongly agree, 5=Strongly disagree.
|
Baseline and 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jan Bergmanson, OD PhD, Texas Eye Research and Technology Center (TERTC), School of Optometry, University of Houston
- Principal Investigator: Pete Kollbaum, OD PhD, Clinical Optics Research Lab (CORL), Indiana University School of Optometry, Indiana University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2014
Primary Completion (Actual)
April 1, 2016
Study Completion (Actual)
April 1, 2016
Study Registration Dates
First Submitted
July 15, 2014
First Submitted That Met QC Criteria
July 15, 2014
First Posted (Estimate)
July 17, 2014
Study Record Updates
Last Update Posted (Actual)
July 29, 2020
Last Update Submitted That Met QC Criteria
July 19, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV-14-05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
Ohio State UniversityAlcon ResearchRecruitingAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
-
Assiut UniversityCompleted
-
Ashford and St. Peter's Hospitals NHS TrustBausch & Lomb IncorporatedUnknown
-
Carl Zeiss Meditec, Inc.CompletedMixed AstigmatismUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
Clinical Trials on comfilcon A Toric
-
CooperVision International Limited (CVIL)Centre for Ocular Research & Education, CanadaRecruiting
-
CooperVision, Inc.CompletedAstigmatism | MyopiaUnited States
-
CooperVision International Limited (CVIL)Centre for Ocular Research & Education, CanadaCompletedAstigmatismUnited States, Canada
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.CompletedPresbyopia | AstigmatismUnited Kingdom
-
CooperVision, Inc.CompletedPresbyopia | AstigmatismUnited States, Canada
-
CooperVision, Inc.CompletedAstigmatism | MyopiaUnited Kingdom
-
Alcon ResearchCompletedRefractive Error | Astigmatism | Myopia | Hyperopia
-
Ohio State UniversityCompletedContact LensUnited States